先聲藥業(02096.HK)舌下片新藥上市申請獲受理

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

先聲藥業(02096.HK)舌下片新藥上市申請獲受理

阿思達克 06-29 01:57

先聲藥業(02096.HK)公布，集團與南京寧丹新藥合作的先必新舌下片(依達拉奉右莰醇舌下片)新藥上市申請獲中國國家藥品監督管理局受理，用於改善急性缺血性腦卒中所致的神經症狀、日常生活活動能力和功能障礙。

先聲藥業(02096.HK)

Relevant Stocks

先聲藥業(02096.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

先聲藥業(02096.HK)舌下片新藥上市申請獲受理

Services

About Us

Agreement Statement